Shira Felder

Department:

Radiation Oncology

Professional Summary

Dr. Shira Felder is a senior radiation oncologist specializing in the treatment of gynecologic and urologic malignancies. She has extensive expertise in advanced radiotherapy techniques, including VMAT, IMRT, SBRT, and brachytherapy, with a particular focus on personalized, precision-based cancer treatment.

Her clinical work is centered on delivering highly targeted radiation therapy to optimize outcomes while minimizing toxicity and preserving quality of life.

Areas of Expertise

1. Gynecologic oncology (cervical, uterine, ovarian, vaginal, and vulvar cancers)
2. Brachytherapy for gynecologic tumors
3. Intensity-Modulated Radiotherapy (IMRT) and VMAT
4. Stereotactic Body Radiotherapy (SBRT)
5. Urologic malignancies (prostate, bladder, and kidney cancers)

Current Positions

Head of the Gynecologic Oncology Service, Department of Radiation Oncology, Sheba Medical Center

Senior Physician, Radiation Oncology Division, Cancer Center

Professional Memberships

Israeli Medical Association – Oncology Division

Israeli Society of Gynecologic Oncology

European Society for Radiotherapy & Oncology (ESTRO)

College of Physicians and Surgeons of Ontario (CPSO)

Canadian Medical Association (CMA)

Education and Training

MD, Hadassah Medical School, Hebrew University of Jerusalem, Israel

Residency in Radiation Oncology, Sheba Medical Center

Fellowship, Radiation Medicine Program, University of Toronto & Princess Margaret Cancer Centre, Canada

Board Certification

Radiation Oncology

Selected Publications

Analysis of patient safety events in brachytherapy within an academic radiation oncology program

Stereotactic ablative radiotherapy for stage I lung cancer: single-center retrospective study (Israel)

Impact of treatment delays on survival in cervical cancer patients: historical cohort study

Vitamin D deficiency in oncology patients: implications for hypocalcemia and quality of lifeVitamin D deficiency in oncology patients–an ignored condition: impact on hypocalcemia and quality of life.